Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
The latest update is out from Sarepta Therapeutics ( (SRPT) ).
Sarepta Therapeutics, Inc. has welcomed Deirdre Connelly to its board of directors, immediately taking up her new role and set to serve until the 2026 annual meeting. She was awarded compensation in the form of restricted stock units and stock options worth $712,500, which will vest over three years, along with an annual cash payment of $60,000. Additionally, the company has expanded its board capacity from eight to nine members to accommodate this new appointment.
For detailed information about SRPT stock, go to TipRanks’ Stock Analysis page.
